Physician profile
Cielo Chavez
NPI 1780193656
$3,232.19
in general payments reported to CMS, 2019-2025
18 companies · $204 in 2025
The $204 reported for 2025 was more than what a typical Nurse Practitioner provider received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $727 · 2022: $225 · 2023: $1,061 · 2024: $1,015 · 2025: $204.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,820 · Travel and Lodging: $460.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,820.17 |
| Travel and Lodging | $460.21 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Silk Road Medical, INC. | $946.88 | 2024 | Enroute Transcarotid Neuroprotection System, Enroute Transcarotid Stent, Enroute Enflate Transcarotid Rx Balloon Dilatation Catheter |
| Astrazeneca Pharmaceuticals Lp | $458.97 | 2021 | |
| E.R. Squibb & Sons, L.L.C. | $345.43 | 2022-2023 | Opdivo |
| Daiichi Sankyo INC. | $248.20 | 2021-2023 | Enhertu |
| Boston Scientific Corporation | $151.70 | 2024-2025 | Eluvia, Varithena Administration Pack |
| Genentech USA, INC. | $144.94 | 2021 | |
| Abbvie INC. | $124.99 | 2023 | |
| Regeneron Healthcare Solutions, INC. | $124.81 | 2023 | Libtayo |
| Stemline Therapeutics INC. | $121.87 | 2023 | Orserdu |
| Seagen INC. | $121.87 | 2023 | Padcev |
| Janssen Biotech, INC. | $121.81 | 2023 | Carvykti, Darzalex, Tecvayli |
| Incyte Corporation | $109.16 | 2023 | Monjuvi |
| Medical Device Business Services, INC. | $71.69 | 2023 | Vistaseal |
| Janssen Pharmaceuticals, INC | $39.67 | 2024 | Xarelto |
| Stryker Corporation | $29.12 | 2025 | Artix Mt |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Endologix LLC | $26.78 | 2025 | Torus Stent Graft System, Endocross Device |
| Getinge USA Sales, LLC | $25.69 | 2025 | Flixene |
| Lilly USA, LLC | $18.61 | 2023 | Verzenio |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Cielo Chavez listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.